Cancer Stem Cell News
Cell Therapy News
Dermal Cell News
Endothelial Cell News
ESC & iPSC News
Extracellular Matrix News
Hematopoiesis News
Hepatic Cell News
Human Immunology News
Immune Regulation News
Intestinal Cell News
Mammary Cell News
Mesenchymal Cell News
Muscle Cell News
Neural Cell News
Organoid News
Pancreatic Cell News
Prostate Cell News
Pulmonary Cell NewsThe authors investigated the safety and efficacy of fazirsiran, an RNA interference therapeutic, in patients with liver disease associated with alpha1-antitrypsin deficiency.
[New England Journal of Medicine]
Home Newsletters Hepatic Cell News Fazirsiran for Liver Disease Associated With Alpha1-Antitrypsin Deficiency
